# Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

> **NCT01674634** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 715 (actual)

## Conditions studied

- Dupuytren's Contracture

## Interventions

- **BIOLOGICAL:** XIAFLEX / XIAPEX

## Key facts

- **NCT ID:** NCT01674634
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 715 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674634, "Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01674634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*